Johnson Investment Counsel Inc. Sells 1,158 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Johnson Investment Counsel Inc. reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 23.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,825 shares of the financial services provider’s stock after selling 1,158 shares during the period. Johnson Investment Counsel Inc.’s holdings in iShares Biotechnology ETF were worth $525,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of IBB. Global Assets Advisory LLC bought a new position in iShares Biotechnology ETF in the first quarter worth about $66,059,000. BNP Paribas Financial Markets increased its stake in shares of iShares Biotechnology ETF by 25.7% during the first quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock valued at $282,038,000 after purchasing an additional 420,053 shares in the last quarter. Gray Foundation bought a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $17,890,000. Jane Street Group LLC purchased a new position in shares of iShares Biotechnology ETF during the first quarter valued at approximately $14,386,000. Finally, Miller Investment Management LP boosted its position in shares of iShares Biotechnology ETF by 2,394.4% in the 4th quarter. Miller Investment Management LP now owns 90,122 shares of the financial services provider’s stock worth $12,243,000 after purchasing an additional 86,509 shares in the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $147.81 on Friday. The business’s fifty day simple moving average is $145.10 and its two-hundred day simple moving average is $138.28. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $150.17.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.